Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR5V1 Inhibitors

OR5V1 inhibitors represent a class of chemical compounds designed to interact specifically with the OR5V1 receptor, which is part of the olfactory receptor family. Olfactory receptors (ORs) are G protein-coupled receptors located primarily in the nasal epithelium, playing a key role in the detection of odorant molecules. The OR5V1 receptor is one of many in the expansive olfactory receptor gene family, which is known for its significant diversity and ability to bind a wide range of volatile chemical compounds. These receptors are activated by distinct ligands, typically small organic molecules, and relay sensory information via signal transduction pathways involving G proteins. OR5V1 inhibitors, therefore, are designed to bind to the receptor and block its activity, preventing the normal activation of the receptor by its natural ligands.

The molecular structure of OR5V1 inhibitors is typically tailored to fit the specific binding pocket of the OR5V1 receptor. This requires a high level of specificity in the design of the inhibitors, often involving the manipulation of molecular frameworks that mimic or compete with the receptor's endogenous odorant ligands. Inhibition of OR5V1 may occur through competitive binding, where the inhibitor directly competes with the natural ligand, or via allosteric mechanisms, where the inhibitor binds to a separate site on the receptor, inducing conformational changes that prevent activation. Research into OR5V1 inhibitors involves extensive study of the receptor's three-dimensional structure, ligand-receptor interaction dynamics, and the biophysical properties that underlie the inhibition process, offering insights into how olfactory signals are modulated at the molecular level.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Zinc

7440-66-6sc-213177
100 g
$48.00
(0)

Zinc acetate can bind to and directly inhibit OR5V1 by altering the protein's conformation or its odorant binding site.

Copper(II) sulfate

7758-98-7sc-211133
sc-211133A
sc-211133B
100 g
500 g
1 kg
$46.00
$122.00
$189.00
3
(1)

Copper(II) sulfate can directly inhibit OR5V1 by binding to the protein, potentially disrupting its structure and function.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine can embed in cellular membranes and alter their properties, which could lead to the inhibition of OR5V1 function.

Lidocaine

137-58-6sc-204056
sc-204056A
50 mg
1 g
$51.00
$131.00
(0)

Lidocaine can stabilize the inactive conformation of ion channels, thereby inhibiting the membrane potential regulation of OR5V1.

Quinine

130-95-0sc-212616
sc-212616A
sc-212616B
sc-212616C
sc-212616D
1 g
5 g
10 g
25 g
50 g
$79.00
$104.00
$166.00
$354.00
$572.00
1
(0)

Quinine's ion channel blocking properties can inhibit ion fluxes and indirectly inhibit the signaling pathways involving OR5V1.

Ruthenium red

11103-72-3sc-202328
sc-202328A
500 mg
1 g
$188.00
$250.00
13
(1)

Ruthenium red inhibits calcium channels, which could lead to inhibition of OR5V1 by disrupting calcium-dependent signaling.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Verapamil inhibits calcium channels and can inhibit OR5V1 by affecting the calcium ion influx necessary for its activity.

Diltiazem

42399-41-7sc-204726
sc-204726A
1 g
5 g
$209.00
$464.00
4
(1)

Diltiazem inhibits calcium channels, which can lead to inhibition of OR5V1 by altering calcium-mediated signal transduction.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

Nifedipine inhibits calcium channels and can inhibit OR5V1 by preventing calcium-dependent signaling mechanisms.

Amiloride

2609-46-3sc-337527
1 g
$296.00
7
(1)

Amiloride inhibits sodium channels, which can inhibit OR5V1 by disrupting sodium ion homeostasis and membrane potential.